| Hypersensitivity to Nadroparin, Cerebrovascular hemorrhage or other active hemorrhage (except DIC), Cerebral Aneurysm, Severe and uncontrolled Hypertension (risk of cerebral hemorrhage), Severe Gastric or Duodenal ulcer, unless it is the reason for surgery, Acute bacterial Endocarditis, Diabetic Retinopathy, positive in vitro aggregation test in presence of Nadroparin in patients with a history of Heparin-associated Thrombocytopenia. |